Skip to main content
. 2017 Sep 22;7:12207. doi: 10.1038/s41598-017-12367-7

Figure 2.

Figure 2

Cell proliferation under each treatment condition, graphically represented by the mean proliferation curves +/− standard deviation. Blue curve, control; black curve, pertuzumab 20 μg/mL; red curve, cetuximab 5 nM; green curve, cetuximab 5 nM + pertuzumab 20 μg/mL. Cell proliferation was measured by an IncuCyte Zoom basic analyser for each cell line under the following treatment conditions: control; cetuximab 5 nM; pertuzumab 20 μg/mL; cetuximab 5 nM + pertuzumab 20 μg/mL; 10 Gy; 10 Gy + cetuximab 5 nM; 10 Gy + pertuzumab 20 μg/mL; 10 Gy + cetuximab 5 nM + pertuzumab 20 μg/mL. Each experiment was performed in triplicate.